FDA Ad Warning Letters On Track For Significant Increase In 2005
Executive Summary
FDA is on track for a significant increase in the number of warning letters issued to drug marketers for advertising violations in 2005
You may also be interested in...
FDA Ad Division Letter Surge Shows Focus On Prominence Of Risk Information
An upcoming FDA draft guidance on fair balance in promotional materials could benefit manufacturers following a spate of warning letters from the agency's ad division citing the prominence of risk information
FDA Ad Division Letter Surge Shows Focus On Prominence Of Risk Information
An upcoming FDA draft guidance on fair balance in promotional materials could benefit manufacturers following a spate of warning letters from the agency's ad division citing the prominence of risk information
DTC Restrictions Ahead: Risk Management Plans, “Drug Watch” Are Vehicles
FDA will manifest its tougher stance on DTC advertising in requirements for more extensive risk management plans, Hogan & Hartson Partner Robert Brady predicted at a Regulatory Affairs Professionals Society conference in Chicago
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: